Short answer · Medically reviewed summary · Last updated: 2026-04-06
The global prevalence of Vitiligo is estimated to be between 0.5% and 2% of the general population, making it a relatively common autoimmune condition rather than a rare or ultra-rare disease. Epidemiological Distribution While Vitiligo is not categorized as a "rare disease" by most regulatory standards, it remains a significant global health concern. Incidence rates are difficult to pinpoint precisely due to the lack of mandatory reporting registries.
What is the prevalence of Vitiligo?
Prevalence of Vitiligo: how many people are affected worldwide, differences by sex and region, with sources.
The global prevalence of Vitiligo is estimated to be between 0.5% and 2% of the general population, making it a relatively common autoimmune condition rather than a rare or ultra-rare disease.
Epidemiological Distribution
While Vitiligo is not categorized as a "rare disease" by most regulatory standards, it remains a significant global health concern. Incidence rates are difficult to pinpoint precisely due to the lack of mandatory reporting registries. Current data suggests that Vitiligo affects males and females with roughly equal frequency, though women may seek clinical evaluation more often due to sociocultural factors related to appearance. Age of onset is highly variable; while it can manifest at any age, approximately 50% of individuals develop Vitiligo before the age of 20, and roughly 25% experience onset before age 10.
Variations and Challenges
There is no definitive evidence of significant geographic or ethnic variation in the prevalence of Vitiligo, though the condition is often more clinically apparent in individuals with darker skin tones, which may influence diagnosis rates. A major challenge in determining accurate prevalence is the high rate of underdiagnosis; many individuals with mild or limited depigmentation may never seek medical intervention. Furthermore, in some regions, Vitiligo is stigmatized, leading to lower reporting in clinical settings.
Real-World Insights
At DiseaseMaps.org, our community of 644 individuals living with Vitiligo provides a vital, real-world perspective that complements traditional clinical data. By aggregating patient-reported experiences, our community helps bridge the gap between textbook statistics and the lived reality of those navigating the condition, highlighting the diverse ways it presents across different populations.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- Global Vitiligo Foundation
- OMIM (Online Mendelian Inheritance in Man)
